Indeed, in previous reports it has been described that HSP90 (both HSP90α and HSP90β) increases the risk of recurrence and distant metastases in triple negative and ER+/HER2- breast cancer subtypes, as well as strongly associates with the risk of death from breast cancer43. Here, HSP90AB1 is linked to breast carcinoma.